Psychotherapy Expectations and Distress Among Mental Health Patients and Their Therapists.
Launched by SHALVATA MENTAL HEALTH CENTER · Mar 27, 2025
Trial Information
Current as of July 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how patients' expectations about psychotherapy (talk therapy) relate to their feelings of distress while they are receiving treatment in psychiatric hospitals or community clinics. The goal is to understand if having positive expectations can help reduce distress among patients. The study will involve patients at Shalvata Mental Health Center, where they will answer questionnaires about their feelings and expectations at different times during their treatment, such as when they start therapy and after several weeks. Their therapists will also provide feedback.
To be eligible for this trial, participants must be Hebrew speakers receiving treatment at Shalvata MHC. However, those who have difficulty understanding Hebrew or are in a very unstable mental state, including those with severe agitation or suicidal thoughts, cannot take part. Participants can expect to fill out questionnaires with the help of staff members or on their own through a mobile link, and the research team will ensure that their safety is a top priority during the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hebrew mother tongue speakers
- • Being treated at Shalvata MHC.
- Exclusion Criteria:
- • Inability to read or comprehend Hebrew due to any reason.
- • Agitative patients
- • Acute suicidal patients
- • Patients in unstable psychotic state
About Shalvata Mental Health Center
Shalvata Mental Health Center is a leading clinical trial sponsor dedicated to advancing mental health treatment through innovative research and evidence-based practices. With a commitment to improving the quality of life for individuals facing mental health challenges, Shalvata collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials. The center focuses on developing and evaluating novel therapies, ensuring the highest ethical standards and participant safety. Through its comprehensive approach, Shalvata aims to contribute to the scientific understanding of mental health disorders and enhance therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Israel, , Israel
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported